Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and Snoring
Primary Purpose
Sleep Apnea Syndromes, Snoring, Disorders of Excessive Somnolence
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Mandibular repositioning appliance, adjustable
Sponsored by
About this trial
This is an interventional treatment trial for Sleep Apnea Syndromes focused on measuring Sleep apnea syndromes, Snoring, Mandibular advancement, Activator appliances, Disorders of excessive somnolence, Blood pressure, Inflammation, Oxidative stress, Hormones, Markers of Metabolic Syndrome X
Eligibility Criteria
Inclusion Criteria:
- Obstructive sleep apnea, apnea-hypopnea index of <30 with excessive daytime sleepiness
- Snoring with excessive daytime sleepiness, apnea-hypopnea index of <5
- Body mass index of <35
Exclusion Criteria:
- Unable to give informed consent
- Psychiatric disorders including dementia that may interfere with the study protocol
- Other concomitant diseases that demand acute, effective treatment of sleep apnea
- Pharyngeal soft tissue abnormalities
- Living to far away from the University Hospital
- Professional drivers
- Pregnancy
- Included in other studies
- Other sleep apnea treatments
- Severe craniomandibular disorders
- Acute or advanced periodontal disease
- Insufficient number of teeth
Sites / Locations
- Depts of Respiratory Medicine and Orthodontics, Umeå University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
1
2
Arm Description
Adjustable mandibular repositioning appliance
Placebo device in upper jaw
Outcomes
Primary Outcome Measures
Sleep apnea and sleep measured by polysomnography
Daytime sleepiness and sleep apnea symptoms assessed in questionnaires and objective testing
Quality of life
Secondary Outcome Measures
Headaches
Blood pressure
Vigilance
Markers of stress
Markers of inflammation
Markers of cardiovascular health and oxidative stress
Side-effects from the treatment
Predictors of effects on symptoms and sleep apneas
Full Information
NCT ID
NCT00477009
First Posted
May 21, 2007
Last Updated
January 17, 2013
Sponsor
Umeå University
Collaborators
The Swedish Research Council
1. Study Identification
Unique Protocol Identification Number
NCT00477009
Brief Title
Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and Snoring
Official Title
A Randomized Controlled Trial of Effects From a Mandibular Advancement Device in Patients With Obstructive Sleep Apnea and Snoring
Study Type
Interventional
2. Study Status
Record Verification Date
January 2013
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
December 2011 (Actual)
Study Completion Date
December 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Umeå University
Collaborators
The Swedish Research Council
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate effects from a mandibular repositioning appliance on obstructive sleep apneas, symptoms, blood pressure and markers of stress, inflammation and cardiovascular health in patients with mild to moderate obstructive sleep apnea/hypopnea syndrome and in patients with symptomatic snoring.
Detailed Description
Mandibular repositioning appliances for the treatment of snoring and sleep apneas are increasingly used over the world, although the number of prescriptions of this therapy varies between countries. The appliance widens the upper airways during sleep in order to reduce sleep-disordered breathing. The device is easy to use and has become popular among patients. Despite this, the evidence for effects of this treatment is not very strong and based on only a few studies. The aim of this study is therefore to test the hypothesis that a mandibular repositioning appliance reduces sleep apneas, daytime sleepiness and other sleep apnea symptoms and increases the quality of life in sleepy patients with mild to moderate obstructive sleep apnea and in patients with symptomatic snoring. Secondary outcomes include effects on headaches, blood pressure and markers of stress, inflammation, cardiovascular health and oxidative stress. At baseline and after 4 month's treatment, the patients will respond to questionnaires about symptoms and quality of life. They will undergo measurements of sleepiness, sleep apneas and blood pressure as well as sampling of saliva, urine and blood. Factors that predict a successful treatment outcome will be analyzed in order to more exactly clarify the indications for this treatment modality in a group of patients who have been suggested to benefit from mandibular repositioning appliances according to previous studies and reviews.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea Syndromes, Snoring, Disorders of Excessive Somnolence
Keywords
Sleep apnea syndromes, Snoring, Mandibular advancement, Activator appliances, Disorders of excessive somnolence, Blood pressure, Inflammation, Oxidative stress, Hormones, Markers of Metabolic Syndrome X
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
96 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Adjustable mandibular repositioning appliance
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
Placebo device in upper jaw
Intervention Type
Device
Intervention Name(s)
Mandibular repositioning appliance, adjustable
Other Intervention Name(s)
Herbst appliance
Intervention Description
Comparison between mandibular repositioning appliance for nightly use and a placebo device regarding effects on sleep apneas and daytime symptoms as well as blood pressure and markers of oxidative stress and sleepiness.
Primary Outcome Measure Information:
Title
Sleep apnea and sleep measured by polysomnography
Time Frame
Baseline and after 4 months
Title
Daytime sleepiness and sleep apnea symptoms assessed in questionnaires and objective testing
Time Frame
Baseline and after 4 months
Title
Quality of life
Time Frame
Baseline and after 4 months
Secondary Outcome Measure Information:
Title
Headaches
Time Frame
Baseline and after 4 months
Title
Blood pressure
Time Frame
Baseline and after 4 months
Title
Vigilance
Time Frame
Baseline and after 4 months
Title
Markers of stress
Time Frame
Baseline and after 4 months
Title
Markers of inflammation
Time Frame
Baseline and after 4 months
Title
Markers of cardiovascular health and oxidative stress
Time Frame
Baseline and after 4 months
Title
Side-effects from the treatment
Time Frame
After 4 months treatment
Title
Predictors of effects on symptoms and sleep apneas
Time Frame
After 4 months treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Obstructive sleep apnea, apnea-hypopnea index of <30 with excessive daytime sleepiness
Snoring with excessive daytime sleepiness, apnea-hypopnea index of <5
Body mass index of <35
Exclusion Criteria:
Unable to give informed consent
Psychiatric disorders including dementia that may interfere with the study protocol
Other concomitant diseases that demand acute, effective treatment of sleep apnea
Pharyngeal soft tissue abnormalities
Living to far away from the University Hospital
Professional drivers
Pregnancy
Included in other studies
Other sleep apnea treatments
Severe craniomandibular disorders
Acute or advanced periodontal disease
Insufficient number of teeth
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie Marklund
Organizational Affiliation
Umeå University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Depts of Respiratory Medicine and Orthodontics, Umeå University
City
Umeå
ZIP/Postal Code
SE-906 51
Country
Sweden
12. IPD Sharing Statement
Citations:
PubMed Identifier
15078734
Citation
Marklund M, Stenlund H, Franklin KA. Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest. 2004 Apr;125(4):1270-8. doi: 10.1378/chest.125.4.1270.
Results Reference
background
PubMed Identifier
16437488
Citation
Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004435. doi: 10.1002/14651858.CD004435.pub3.
Results Reference
background
PubMed Identifier
29929990
Citation
Rietz H, Franklin KA, Carlberg B, Sahlin C, Marklund M. Nocturnal Blood Pressure Is Reduced by a Mandibular Advancement Device for Sleep Apnea in Women: Findings From Secondary Analyses of a Randomized Trial. J Am Heart Assoc. 2018 Jun 21;7(13):e008642. doi: 10.1161/JAHA.118.008642.
Results Reference
derived
PubMed Identifier
26030264
Citation
Marklund M, Carlberg B, Forsgren L, Olsson T, Stenlund H, Franklin KA. Oral Appliance Therapy in Patients With Daytime Sleepiness and Snoring or Mild to Moderate Sleep Apnea: A Randomized Clinical Trial. JAMA Intern Med. 2015 Aug;175(8):1278-85. doi: 10.1001/jamainternmed.2015.2051.
Results Reference
derived
Learn more about this trial
Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and Snoring
We'll reach out to this number within 24 hrs